Pharmeasy Unlisted Shares

Pharmeasy Unlisted Shares

BUY AT INR 22.0

2/5
Most Active

Key Indicators

KEY INDICATOR
2022
FACE VALUE/SHARE
1.0
BOOK VALUE/SHARE
11.0
PRICE TO EARNING (PE)
-3.6
PRICE/SALES
2.5
PRICE/BOOK
2.4
MARKET CAP(Rs.Million)
143806.0
DEBT/EQUITY
0.6
DIVIDEND/SHARE
0.0
DIVIDEND % (ON CMP)
0.0%
RETURN ON TOTAL ASSETS
-12.9%
RETURN ON EQUITY
-21.0%
ROWC
-21.3%

* Ratio is calculated based on latest financial & current share price.

About The Company

API Holdings Limited (Pharmeasy), as per its annual filings, is engaged in the business of undertaking and/or arranging or syndicating all types of business relating to the financing of industry or corporates like logistic and IT sectors. Further, during the year under review, the company had transferred its businesses of wholesale and distribution of drugs (including pharmaceutical products, medical devices, and OTC drugs) and ownership of technology and intellectual property for developing e-commerce platforms including marketplaces for facilitating the sale of pharmaceutical, medical devices, and OTC drugs to its wholly-owned subsidiaries through a slump sale on a going concern basis.
Read More

Management

Mr Siddharth Shah
CEO & Managing Director
Mr Abhinav Jain Ranka
Chief Financial Officer
Mr Ajinkya Jain
Company Secretary

Financials

Revenue Growth %

EBDITA Margin %

EPS Growth %

Profit & Loss Summary

(All Amount in INR Millions)

PROFIT & LOSS
2022
2021
2020
PROFIT & LOSS
2022
2021
2020
REVENUE
57810
23607
7374
REVENUE
57810
23607
7374
EXPENSE
80745
29046
10537
EXPENSE
80745
29046
10537
EBDITA
-23457
-5693
-3862
EBDITA
-23457
-5693
-3862
OTHER COST
-8438
763
307
OTHER COST
-8438
763
307
PBT
-39714
-6203
-3470
PBT
-39714
-6203
-3470
Income Tax
217
211
-117
Income Tax
217
211
-117
PAT
-39932
-6413
-3353
PAT
-39932
-6413
-3353
OTHER INCOME/EXP.
-345
51
1
OTHER INCOME/EXP.
-345
51
1
INCOME (NET OF TAXES)
-40277
-6362
-3352
INCOME (NET OF TAXES)
-40277
-6362
-3352
OUTSTANDING SHARE
5531
2387
2387
OUTSTANDING SHARE
5531
2387
2387
EPS ( Rs/share)
-7.3
-2.7
-1.5
EPS ( Rs/share)
-7.3
-2.7
-1.5

Balance Sheet

(All Amount in INR Millions)

BALANCE SHEET
2022
2021
2020
BALANCE SHEET
2022
2021
2020
CASH & CASH EQUIVALENT
3292
3232
585
CASH & CASH EQUIVALENT
3292
3232
585
NON CURRENT ASSET
88961
35872
968
NON CURRENT ASSET
88961
35872
968
CURRENT ASSET
21730
9949
4172
CURRENT ASSET
21730
9949
4172
TOTAL ASSET
113983
49053
5725
TOTAL ASSET
113983
49053
5725
EQUITY SHARE CAPITAL
6142
256
0
EQUITY SHARE CAPITAL
6142
256
0
RESERVES
64083
35556
2462
RESERVES
64083
35556
2462
TOTAL EQUITY
70225
35812
2462
TOTAL EQUITY
70225
35812
2462
NON CURRENT LIABILITY
6142
3480
1987
NON CURRENT LIABILITY
6142
3480
1987
CURRENT LIABILITY
37616
9762
1275
CURRENT LIABILITY
37616
9762
1275
TOTAL LIABILITIES
43758
13242
3262
TOTAL LIABILITIES
43758
13242
3262
TOTAL EQUITY & LIABILITY
113983
49053
5725
TOTAL EQUITY & LIABILITY
113983
49053
5725

Cash Flow Summary

(All Amount in INR Millions)

CASH FLOW
2022
2021
2020
CASH FLOW
2022
2021
2020
OPERATING ACTIVITY
-25894
-8137
-4453
OPERATING ACTIVITY
-25894
-8137
-4453
INVESTING ACTIVITY
-57892
45
-1904
INVESTING ACTIVITY
-57892
45
-1904
FINANCING ACTIVITY
83054
10190
6296
FINANCING ACTIVITY
83054
10190
6296
NET CASH FLOW
-732
2098
-60
NET CASH FLOW
-732
2098
-60

Shareholders

Shareholders
API Holdings Ltd
Siddharth Bhaskar Shah
Harsh Shailesh Parekh
Dhaval Rajesh Shah
Others
%
71.1
3.5
0.38
0.1
24.9

Registered Address

Annual Reports

NEWS

48
Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parent
21
Pharmeasy in talks with PE firms to raise $250 mn debt
19
PharmEasy wins CNBC-TV18’s IBLA Young Turk of the Year Award
21
Aamir Khan is PharmEasy's brand ambassador
newss
IPOs to watch out for once the primary market starts buzzing
48
PharmEasy not in pink of health, shares drop 50% in unlisted market
19
An unexciting start for Thyrocare-PharmEasy combine
48
PharmEasy parent company gets Sebi nod for Rs 6,250-cr public offer
19
SEBI gives approval to three more IPOs, including PharmEasy
48
PharmEasy may have to rework IPO valuation as street mood swings
31
After chemists' body, traders' body CAIT urges SEBI to reject PharmEasy's IPO request
28
Traders' body approaches SEBI against PharmEasy IPO plans
19
PharmEasy parent API Holdings files DRHP for IPO
59
Pharmeasy's intuitive commercials, making pharmaceutical purchases as seamless as possible.
24
PharmEasy valued at $5.6 billion in pre-IPO round
19
PharmEasy raises $350 million in pre-IPO round: Report
48
PharmEasy in talks to raise upto $300 million, valuation may drop by half
48
PharmEasy pulls out market listing plan
48
PharmEasy Floats Rights Issue to Raise ₹750 crore
19
PharmEasy’s annus horribilis may get worse before it gets better
2
PharmEasy’s Parent Raises Debt Funding
Load More

Frequently Asked Questions On PharmEasy Unlisted Shares

Due to past performance and potential to grow, investment in API Holdings Ltd(PharmEasy) unlisted shares is a wise choice. At Stockify, you can easily buy and sell unlisted shares of API Holdings Ltd(PharmEasy). You just need to connect with our expert share brokers, and they will help you throughout the process.
If you are wondering how to sell API Holdings Ltd(PharmEasy) shares online, just fill out basic details in the form and our experts will get back to you. Right from the initial deal to the final transfer of shares, our unlisted share brokers will help. Check out the list of the best unlisted shares in India or reach out to reputed unlisted share dealers online.
SEBI has recently reduced the lock-in period from 1 year to 6 months. There is a minimum lock-in period of 6 months from the date of purchase of unlisted shares. However, these shares can be freely transferable before listing in NSE/BSE. Connect with unlisted share experts at +91-80 4113 3935/+91-7353266646
In the recent, unlisted share market in India is spreading its wings and becoming quite big. Some highly recognized companies like Reliance, HDB finance and even the National Stock Exchange are trading unlisted stocks. At Stockify, we allow you to buy and sell any number of API Holdings Ltd(PharmEasy) unlisted shares as per your budget or needs. Customise your unlisted share trading experience.
Yes, this is 100% legal and safe to buy unlisted shares of API Holdings Ltd(PharmEasy). However, this is applicable when you buy API Holdings Ltd(PharmEasy) unlisted shares from reliable and known unlisted share dealers. You can request a quote or trade online at Stockify, we are ready to assist you.
There is no difference between the tax of unlisted and listed shares. Short-term capital gain taxes are usually paid on the profit of shares held for one year or less. A rate of 15% will be charged as STCG tax and surcharges will be added based on the period of your holding. Buying unlisted shares in bulk? Talk to our experts to learn more.
Applicability of Taxes on API Holdings Ltd(PharmEasy) unlisted shares once it is listed?
The credit transfer process is also the same for both listed and unlisted stocks. Once the share is transferred it will be reflected in your depositary/Demat account NSDL/CDSL. You can also check it online by logging into the NSDL/CDSL account.
At Stockify, we have simplified the whole process of unlisted share trading. A basic KYC is required for investing in unlisted stocks. For KYC verification, you will need to show Adhar | PAN | Demat CML For NRI |PAN|DEMAT CML| NRO Bank statement. Want to know more about how to buy unlisted shares in India? Connect with expert share brokers today!
There are multiple factors such as Demand/Supply of shares, valuation of the companies & multiple other factors that affect the returns on any unlisted shares. For eg. Investment of 1 Lakh in CSK shares in 2019 is worth 20 lakhs today in 2022 (20x returns in just 3 year). The return on investment of unlisted shares also varies depending on the period of holding. Estimating a return on unlisted shares requires in-depth knowledge and understanding of the industry. So, you can connect with our unlisted share experts to get a greater share of profit
Due to past performance and potential to grow, investment in API Holdings Ltd(PharmEasy) unlisted shares is a wise choice. At Stockify, you can easily buy and sell unlisted shares of API Holdings Ltd(PharmEasy). You just need to connect with our expert share brokers, and they will help you throughout the process.
Yes, selling and buying PharmEasy unlisted shares is ethical and legal in India. If you are interested in purchasing, connect with the experts at Stockify today, consult the best options for your portfolio and simply buy them with us for hassle-free trading!
Yes, both online and offline DIS is available for PharmEasy unlisted shares. Since Stockify is an online unlisted shares broker, you can simply fill out the online DIS for PharmEasy unlisted shares.
You can buy PharmEasy unlisted shares easily from Stockify. Check out the PharmEasy share price today, consult our experts, spot your requirements and hit “buy”!

Buy PharmEasy shares

PharmEasy is digital India’s digital consumer healthcare app. Referred to as a super app, PharmEasy offers customers on-demand access to home delivery for a comprehensive range of prescriptions and OTC pharmaceuticals. PharmEasy offers consumer healthcare products, information, consultations, and diagnostics tests from renowned laboratories. The company is associated with trusted doctors and registered in-store pharmacies. Birthed in 2015, PharmEasy is currently registered with more than 25 million users. Moreover, with a market capitalization of approximately ₹ 300 crores, PharmEasy unlisted shares are presently a hot shot among investors and financial advisors.

 

Founded by Dharmil Seth and Dr Dhaval Shah, PharmEasy serves every habitable zip code. The initial idea was to give end users an online pharmacy, but with the inclusion of consultation from trusted doctors and diagnostic tests from renowned laboratories, the application turned out to be more comprehensive. Furthermore, the company closed a revenue of ₹5781 crores in the fiscal year 2021.

 

PharmEasy Unlisted Share Price Overview

In the past few months, almost every firm was hit by its all-time low, and so was PharmEasy. However, India’s largest digital healthcare platform boasts the potential to overcome its low. PharmEasy stock price experienced a hike during November and December of 2021. The PharmEasy share price has now come to a still range, varying between ₹ 30 – ₹40 per share price. Moreover, with over 2.4 million transacting consumers, PharmEasy saw a growth rate of 220% in fiscal 2021.

Pharmeasy graph

PharmEasy got its first funding in the year 2016 and got merged with Ascent Health and five other firms to form the most effective digital healthcare platform in India – API Holdings. Currently, the company has a face value of ₹ 1 per equity share and consists of a total of 10000 shares.

 

Why Buy PharmEasy Unlisted Shares?

PharmEasy, with its merger in 2020, has turned out to be the most prominent name in the industry. With API Holdings as the parent company, PharmEasy is determined to show a staging growth rate, and investors are anticipating nothing less from the firm. After Paytm, PharmEasy unlisted share prices are expected to hold the most significant gains. Moreover, PharmEasy share price today is at its best value, catering to the range of ₹ 30 – ₹40 per share. Though the PharmEasy stock price saw a low in the last few months, the data below clearly depicts that investors are not ready to sell their Pharmeasy InfographicPharmEasy unlisted shares, further indicating their belief in the growth.

 

Apart from the great face & brand value, and investor belief, another reason for investing in PharmEasy is the stunning revenue generated by the company. Check the company data below:

Pharmeasy Revenue

From the above data, the growth of PharmEasy unlisted share price can be clearly anticipated to go up. Further, reports suggest that the platform is expected to grow at an annual rate of 18.1% till the end of 2023. Thus, if you want to invest, now is the time! PharmEasy unlisted shares are currently one of the best options for your investment portfolio.

 

How To Apply For PharmEasy Unlisted Shares Online?

PharmEasy unlisted shares are pretty easy to buy, especially with Stockify. We are here with an ensemble of details such as Key Performance Indicators, revenue growth, EBITDA margin reports, EPS growth, etc. Moreover, the experts at Stockify constantly keep track of the trends and changes in the PharmEasy unlisted shares price, and we update our prices as per the market fluctuation every day.

 

PharmEasy stock price is currently the talk of the room; you can check it above. Analyse and compare the key indicators, figure out your requirements and rely on our experts to guide you throughout the PharmEasy unlisted shares buying process. We will take care of everything – from guidance to documentation.

 

Check PharmEasy Unlisted Share Price Today at Stockify

PharmEasy company share price is updated every day here at Stockify. We keep a close eye on PharmEasy stock price fluctuations and immediately update our prices as per the market trends on a daily basis. If you are interested in buying PharEasy Unlisted Shares, stay connected with us and keep a close tab on our prices. You can check the PharmEasy share price today.

 

In case you seek alternatives subscribe to our newsletter – we roll out regular updates regarding PharmEasy share price, market trends, and other indicators which assist in determining whether or not a share is beneficial for your portfolio. PharmEasy unlisted share price India is ₹ 35.7.

 

Check Out Prices Of Other Unlisted Shares On Stockify

Portfolio diversification is essential, especially if you wish to cope with market fluctuations. Diversification is the best way to minimise the blow that hits while the market goes down. Stockify brings an array of unlisted shares from top-rated companies and pre-IPO shares at authentic prices. Apart from buying and selling PharmEasy unlisted shares, look at the best unlisted shares in the market. We bring you unlisted shares from all the sectors – healthcare, insurance, technology, finance, manufacturing, and many more. Take a peek at the PharmEasy share price today and also glance up other unlisted shares hosted by Stockify, as specified below:

 

Reliance Retail, boAT Unlisted Shares, Chennai Super Kings, Anglo-French Drugs & Industries, Hexaware Technologies Ltd, Five Star Business Finance Ltd Unlisted Shares, Fincare Small Finance Bank Ltd Unlisted Shares, Arohan Financial Services Unlisted Shares, Utkarsh Coreinvest Ltd Unlisted Shares, Fino Paytech Ltd Unlisted Shares, Hero Fincorp Ltd Unlisted Shares, National Stock Exchange Ltd Nse Unlisted Shares, National Commodity Derivatives Exchange Ltd Ncdex Unlisted Shares, MetroPolitan Stock Exchange MSEI Unlisted Shares, Capital, Small Finance Bank Ltd Unlisted Shares, and Motilal Oswal Home Finance Ltd Unlisted Shares.

 

Login To Buy PharmEasy Unlisted Shares Today

Read More

SHARE

Stockify Fintech Pvt. Ltd.

Register Your Interest